To further evaluate the regulatory effect of AKT inhibitor MK-2206 on endometrial cancer cell proliferation, WST-8 cell viability assay was performed using HEC-1A and Ishikawa cells after MK-2206 treatment. This evidence concerns the gene AKT1 and endometrial cancer.